Biopanda offers a comprehensive range of Drugs of Abuse Rapid Tests for whole blood, serum and plasma (WB/S/P), providing convenient solutions for the qualitative detection of drugs and drug metabolites in human specimens. Designed for professional drug screening applications, the range includes both individual drug tests and multi-drug rapid test cassettes. With multiple drug combinations and individual screening options available, Biopanda's whole blood, serum and plasma drug tests provide flexible solutions for clinical laboratories, healthcare professionals, medical distributors and other organisations requiring rapid drugs of abuse screening.
Multi-Drug Rapid Test Cassettes
The Biopanda Multi-Drug Rapid Test Cassettes are rapid immunoassays for the simultaneous qualitative detection of drugs and drug metabolites in human whole blood, serum, or plasma.
The below Drugs of Abuse tests for whole blood/serum/plasma may be selected in multi-format cassettes or bought individually.
The below Drugs of Abuse tests for whole blood/serum/plasma are available in individual format only.
Drug testing using whole blood, serum or plasma provides an alternative specimen option for the detection of specific drugs and drug metabolites. These sample types can be particularly relevant within professional healthcare and laboratory environments where blood-derived specimens are already routinely collected and handled.
Rapid drugs of abuse testing provides qualitative screening results without the need for lengthy analytical procedures. Individual rapid tests can be selected when screening for a specific drug or metabolite, while multi-drug blood tests allow several substances to be screened simultaneously from a single specimen.
Biopanda's whole blood, serum and plasma drug tests include individual and multi-drug formats, providing flexible screening options for a range of commonly tested drugs and metabolites.
These rapid tests provide practical screening solutions for clinical laboratories, healthcare professionals and other organisations requiring efficient drug and drug metabolite detection in whole blood, serum or plasma. Where required, preliminary screening results should be interpreted alongside appropriate clinical information and confirmed using a suitable laboratory method.
How to order:
Via the contact us page, fill in the form with all the necessary details and we will email you back ASAP.
Or, email us directly for general queries (please include the product catalogue number in the subject line, if applicable).